Head: Dr. P. Clowes

Stellvertreter/-in: Dr. E. Saathoff, PhD


EMINI (Establishment of the infrastructure to Evaluate and Monitor the Impact of New Interventions, including drugs and vaccines for HIV, TB and malaria) investigates the prevalence and incidence of HIV, Tuberculosis, Malaria, Schistosomiasis and intestinal helminth infections in 9 communities in the Mbeya Region in Tanzania with a total population of 171,133  In addition to annual, population based cross sectional surveys of 10% of the above population, EMINI is reinforcing the existing health infrastructure through technical support, rehabilitation of existing health facilities and continuous training of health care staff.

Infrastructural improvements and the establishment of a community network are creating a platform, on which the impact of new interventions can be assessed. This will allow considering new interventions before they are implemented in larger populations, and thus limit the risk of destroying intact health structures without proof that new interventions are superior to established ones. The annual surveillance system will allow early detection of new trends and patterns in the epidemiology of HIV, TB, malaria, schistosomiasis and intestinal helminth infections, and will help to prepare specific responses.

The initial duration of EMINI was planned for three years, starting mid 2005. However, as the collected data proved to be extremely valuable, an extension of the EMINI annual surveys until mid 2011 has recently been approved.

LMU Department of Infectious Diseases and Tropical Medicine has designed the EMINI study, is managing the study and its laboratory, as well as providing epidemiological support through its team members within the NIMR-Mbeya Medical Research Programme Collaboration.

The project is funded by the European Union through EuropAid, contract number SANTE/2004/078-545 EMINI.